Press release
Galectin Inhibitor Therapeutics - Pipeline Analysis 2019
Download the sample Report @ https://www.pharmaproff.com/request-sample/1209
Many studies have demonstrated role of galectins in the pathogenesis of various diseases including malignant, fibrotic and inflammatory diseases; hence, emerges as an attractive target for the therapeutic of various diseases. Galectin-3 inhibitors has shown positive clinical results for the treatment of acute lymphoblastic leukemia. Thus, providing several opportunities to the companies for the development of galectin-based therapies for the treatment of multiple human diseases.
Get the detailed analysis @ https://www.pharmaproff.com/report/galectin-inhibitor-therapeutics
Galectin Therapeutics Inc. is in the process of developing GR-MD-02 as a galectin-3 inhibitor for the treatment of fibrosis, cancer and plaque psoriasis. It is also being studied in combination with Yervoy and Keytruda, for the treatment of cancer. GlycoMimetics Inc., and Galecto Biotech AB are some other companies having pipeline of galectin inhibitors.
Request for customization @ https://www.pharmaproff.com/request-customization/1209
The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with detailed analysis of pipeline and clinical trials. Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licencing, grants, technology and others.
About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.
Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Galectin Inhibitor Therapeutics - Pipeline Analysis 2019 here
News-ID: 1646100 • Views: …
More Releases from Pharma Proff
Interleukin-6 (IL-6) Inhibitors Analysis, Clinical Trails and Developments
Interleukin-6 (IL-6) inhibitors currently exhibit a proliferating pipeline with 25+ therapeutic candidates.
IL-6 is a cytokine encoded by IL-6 gene, which helps in the maturation of B cells and is actively involved in the inflammatory response. The IL-6 protein is primarily produced at the sites of acute and chronic inflammation, where it is secreted into the serum and brings a transcriptional inflammatory response through IL-6? receptor. This protein is assumed to…
Retinitis Pigmentosa Therapeutics Analysis, Clinical Trials and Other Developmen …
Retinitis pigmentosa therapeutics currently exhibits a proliferating pipeline with 25+ therapeutic candidates.
Retinitis pigmentosa (RP) is a group of hereditary disorders that lead to the breakdown and loss of cells in the retina. Mutation in genes encoding the proteins required by retinal cells for their proper functioning, results in occurrence of RP. The disease results in partial vision loss during the earlier stage of the disease, which may lead to complete…
Probiotics Therapeutics -Pipeline Analysis 2018, Clinical Trials & Results, Pate …
Probiotics are live microorganisms that produces beneficial effects in human gut. Probiotics can be taken as a dietary supplement. They prevent diarrhoea and help to reduce the symptoms of irritable bowel syndrome.
Download the sample report at: https://www.pharmaproff.com/request-sample/1189
Probiotics comprise of a variety of microorganisms belonging to the Lactobacillus and Bifidobacterium groups. The only yeast probiotic that has proven to be effective is Saccharomyces boulardii. According to researchers, probiotics are effective in…
Niemann-Pick Disease Type C (NPC) Therapeutics Pipeline to Witness Significant G …
Niemann-Pick disease is divided into four main types: type A, type B, type C1, and type C2. These types are classified on the basis of genetic cause and signs and symptoms of the disease. NPC is identified as a rare genetic disorder in which the body is unable to transport cholesterol and lipids inside the cells. This causes accumulation of these substances within various tissues of the body. These substances…
More Releases for Galectin
Kidney (Renal) Fibrosis Market 2020 Global Research - Merck, Pfizer, Roche, Inte …
The Kidney (Renal) Fibrosis Market 2020 report is a comprehensive, professional and in-depth research of market that delivers significant data for those who are seeking information for the Kidney (Renal) Fibrosis industry. The market report delivers the specification, key strategies, future prospect and cost structure of the industry. The report also highlighted the future trends in the Kidney (Renal) Fibrosis market that will impact the demand during the forecast period.
Available…
Global Galectin Inhibitor Therapeutics Market 2020:Comprehensive Study By Key Pl …
Global galectin inhibitor therapeutics market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market.
This galectin inhibitor therapeutics report works as a reputable source of information to offer…
Galectin Inhibitor Therapeutics - Pipeline Analysis 2019
Galectins belong to the family of animal lectins and perform function by interacting with cytoplasmic and nuclear proteins, cell-surface and extracellular matrix glycoproteins and glycolipids to modulate signalling pathways. Studies have shown the crucial roles of galectin in cancer as they contribute to tumour cell survival, tumour metastasis, angiogenesis and neoplastic transformation.
Download the sample Report @ https://www.pharmaproff.com/request-sample/1209
Many studies have demonstrated role of galectins in the pathogenesis of various diseases including…
Galectin 3: Market 2019 Top Players and Key Trends | Bristol-Myers Squibb Compan …
Galectin 3 Market Status and Outlook 2019-2025 that centers in industry upgrades, providing analytical and exclusive statistics. Worldwide market trends are analyzed using recently accessible Galectin 3 data pertinent to the sum of the market businesses and their economy share. The global Galectin 3 report highlights the size, share, trends, dynamics and growth, and earnings in addition to leading companies, revenue, ingestion, procedures, and innovative estimations.
REQUEST SAMPLE REPORT WITH TOC:…
Galectin 3 Market Analysis 2018 : Product scope, Overview 2025
Global Galectin 3 Market Size, Status and Forecast 2025 provides a unique tool for evaluating the market, highlighting opportunities, and supporting strategic and tactical decision-making. Galectin 3 Market report recognizes that in this rapidly-evolving and competitive environment, up-to-date marketing information is essential to monitor performance and make critical decisions for growth and profitability. It provides information on trends and developments, and focuses on markets and materials, capacities and technologies, and…
Myocardial Fibrosis Key Players - Evotec AG, Galectin Therapeutics Inc, and Invi …
Myocardial Fibrosis
Overview
Myocardial fibrosis is an abnormal thickening of the heart valves due to inappropriate proliferation of cardiac fibroblasts. Symptoms include chest pain, some abdominal swelling, nausea and fatigue. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
Additionally, various dynamic tracking processes ensure that the most…
